This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
Regardless of instrument or application, Genedata Screener® for High Content Screening enables time-efficient workflow for analysis of high-content experiments.
La Jolla, CA (PRWEB) February 18, 2014
Genedata, a leading provider of advanced software solutions for drug discovery and life science research, will demonstrate Genedata Screener for High Content Screening (HCS) at the 11th annual High Content Analysis conference. Genedata Screener for HCS efficiently analyzes raw data from phenotypic screening experiments performed on a wide range of HCS instruments. Its latest image management capabilities provide full integration of HCS images into the analysis/review workflow as well as enterprise-wide access to images and analysis results. Genedata Screener will be featured in the HCA Technology Showcase (Feb. 19) and demonstrated at the HCA Conference at the San Diego Marriott (Booth #13; Feb. 19 - 20).
Conquering Multi-Instrument HCS Complexity
Biology labs use HCS as the workhorse for all phenotypic-centric screening activities. Oftentimes, images from different instruments must go through the same data analysis workflow and be made available throughout the analysis. Therefore, image management including searching and archiving images can be difficult at best or nearly impossible at worst. Complementary to point solutions, the image management capabilities of Genedata Screener for HCS address the challenges of a multi-instrument environment. Regardless of the HCS instrumentation or HCS software package, Genedata Screener enables streamlined image management and fast secondary analysis in a simple and solid workflow. With Genedata Screener for HCS, scientists can:
Out-of-the box, Genedata Screener integrates with leading HCS instruments, simultaneously supporting multiple HCS systems. With instant access to HCS images, scientists have clear visibility into the data analysis pipeline, enabling easy review of phenotypic changes and discovery of biological events (e.g. during dose response curve fitting). Interactive cell histograms provide analysis of cell populations and calculations of cell-to-well aggregations.
The latest enhancements to Genedata Screener make analysis of phenotypic screening experiments even more user-friendly and efficient while improving the ROI of our customers technology investments, said Dr. Othmar Pfannes, CEO of Genedata. Image management is an area we will continue to advance and its integration in Genedata Screener for HCS shows our commitment to continuously develop Screener and strengthen its position as platform of choice for all plate-based screening.
Genedata transforms data into intelligence with a portfolio of advanced software solutions, which make research data accessible and understandable and research processes more efficient. These solutions are used worldwide by leading pharmaceutical, industrial, and agricultural biotechnology companies as well as academic research organizations. Genedata innovations enable scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Germany, Japan, and the US. http://www.genedata.com. Follow Us on LinkedIn.
For the original version on PRWeb visit: http://www.prweb.com/releases/2014/02/prweb11589339.htm
Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.